The leader in breast care cryoablation
Since the original founding in 1999 as Sanarus Medical Inc., then becoming Sanarus Technologies in 2009, the company has had one mission – to improve the standard of care for breast tumors. We invented and patented a low-pressure liquid nitrogen cryotherapy system that offers a minimally invasive alternative to surgery that's safe and effective.
In 2001, the Visica® Treatment System was the first system available for cryoablation of fibroadenomas. Since then, our systems have been used to treat thousands of successful cases. The Visica has also been used for breast cancer in hundreds of cryo-assisted surgeries and dozens of cryo-only procedures in clinical trials since 2007. At Sanarus, we pride ourselves in pioneering minimally invasive breast care solutions as the clear leader in the field and in clinical studies for both benign tumors and breast cancer.
We are a woman-owned business, headquartered in Pleasanton, CA, and all of our products are manufactured in the U.S.A.